Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras vel sagittis libero, a lacinia nisi. Interdum et malesuada fames ac ante ipsum primis in faucibus. Donec nec nisl turpis. Pellentesque pretium pellentesque maximus. Nam efficitur massa justo, eget laoreet odio congue convallis. Proin sagittis mauris sit amet justo cursus, sit amet porta eros eleifend. Nullam felis tortor, pharetra a consequat eget, luctus non massa. Cras sed efficitur felis, sollicitudin gravida eros. Mauris congue efficitur tempor.
Renseigner une description via Articles > Categories > Homepage Featured Webinar > Champ 'Description' pour remplacer ce Lorem ipsum.
Conversation between a Sponsor and a Statistician about Phase II/III trials in oncology
June 23, 2022
Learn on the features, advantages and disadvantages of adaptive designs and group-sequential designs and their regulatory aspects of Phase II/III trials…
Read more
Risk-Based Fraud Detection: How Centralized Monitoring Can Boost Data Quality
March 24, 2022 — March 24, 2022
This webinar presented the results of a new study that further demonstrated that risk-based monitoring is an efficient tool to…
Download/View
Assessing treatment efficacy in early-phase oncology trials
February 3, 2022
Join IDDI experts to get updated on efficacy assessment in early-phase trials and more! THURSDAY, FEBRUARY 3 – 9:00 –…
Download/View
Assessing activity in early-phase trials in oncology: current designs for expansion cohorts and phase 2
December 2, 2021
Be updated on different types of Bayesian and frequentist designs that may be used for expansion cohorts in phase 1…
Download/View
Biostatistics and SARS-CoV-2: research, policymaking, and communication
September 21, 2021
Learn on the central role of Biostatistics in the COVID-19 Pandemia, and the multidisciplinary nature of pandemic response LISTEN TO…
Download/View